The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model

[1]  You Li,et al.  MiR-206, a Key Modulator of Skeletal Muscle Development and Disease , 2015, International journal of biological sciences.

[2]  C. Niemeyer RAS diseases in children , 2014, Haematologica.

[3]  G. Schratt,et al.  MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites , 2014, Cellular and Molecular Life Sciences.

[4]  H. Harn,et al.  Therapeutic Potential of MicroRNA Let-7: Tumor Suppression or Impeding Normal Stemness , 2014, Cell transplantation.

[5]  P. Fergelot,et al.  Cutaneous Manifestations in Costello and Cardiofaciocutaneous Syndrome: Report of 18 Cases and Literature Review , 2013, Pediatric dermatology.

[6]  N. Selvamurugan,et al.  Regulation of Breast Cancer and Bone Metastasis by MicroRNAs , 2013, Disease markers.

[7]  S. Knuutila,et al.  MicroRNA Profiling in Chemoresistant and Chemosensitive Acute Myeloid Leukemia , 2013, Cytogenetic and Genome Research.

[8]  D. Faller,et al.  Targeting the RAS oncogene , 2013, Expert opinion on therapeutic targets.

[9]  A. Tamura,et al.  Crystal structures of the state 1 conformations of the GTP‐bound H‐Ras protein and its oncogenic G12V and Q61L mutants , 2012, FEBS letters.

[10]  C. Deltas,et al.  microRNAs: a newly described class of encoded molecules that play a role in health and disease. , 2010, Hippokratia.

[11]  C. Angelini,et al.  Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients , 2010, Journal of Translational Medicine.

[12]  Chul-Hong Kim,et al.  p19(ras) Represses proliferation of non-small cell lung cancer possibly through interaction with Neuron-Specific Enolase (NSE). , 2010, Cancer letters.

[13]  G. Brewer,et al.  Impairment of mitochondrial respiration in mouse fibroblasts byoncogenic H-RASQ61L , 2010, Cancer biology & therapy.

[14]  K. Heesom,et al.  P19 H-Ras Induces G1/S Phase Delay Maintaining Cells in a Reversible Quiescence State , 2009, PloS one.

[15]  Zsolt Czimmerer,et al.  DIFFERENTIALLY EXPRESSED MicroRNAs IN SMALL CELL LUNG CANCER , 2009, Experimental lung research.

[16]  D. Kaplan,et al.  Costello syndrome H-Ras alleles regulate cortical development. , 2009, Developmental biology.

[17]  F. Slack,et al.  let-7 microRNAs in development, stem cells and cancer. , 2008, Trends in molecular medicine.

[18]  Jung-Woong Kim,et al.  p19(ras) amplifies p73beta-induced apoptosis through mitochondrial pathway. , 2008, Biochemical and biophysical research communications.

[19]  K. Gripp,et al.  Clarification of previously reported Costello syndrome patients , 2008, American journal of medical genetics. Part A.

[20]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[21]  C. Croce,et al.  MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia , 2007, Oncogene.

[22]  B. White,et al.  The Micro-Ribonucleic Acid (miRNA) miR-206 Targets the Human Estrogen Receptor-α (ERα) and Represses ERα Messenger RNA and Protein Expression in Breast Cancer Cell Lines , 2007 .

[23]  J. Rivas,et al.  Transcriptional networks of knockout cell lines identify functional specificities of H-Ras and N-Ras: significant involvement of N-Ras in biotic and defense responses , 2007, Oncogene.

[24]  J. Hoffman,et al.  Somatic mosaicism for an HRAS mutation causes Costello syndrome , 2006, American journal of medical genetics. Part A.

[25]  K. Gripp,et al.  Paternal bias in parental origin of HRAS mutations in Costello syndrome , 2006, Human mutation.

[26]  O. Dereure Mutations du proto-oncogène H-Ras dans le syndrome de Costello , 2006 .

[27]  Yukichi Tanaka,et al.  Germline mutations in HRAS proto-oncogene cause Costello syndrome , 2005, Nature Genetics.

[28]  Krister Wennerberg,et al.  The Ras superfamily at a glance , 2005, Journal of Cell Science.

[29]  C. Croce,et al.  An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Guil,et al.  Roles of hnRNP A1, SR Proteins, and p68 Helicase in c-H-ras Alternative Splicing Regulation , 2003, Molecular and Cellular Biology.

[31]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[32]  M. Malumbres,et al.  Targeted Genomic Disruption of H-ras and N-ras, Individually or in Combination, Reveals the Dispensability of Both Loci for Mouse Growth and Development , 2001, Molecular and Cellular Biology.

[33]  L. Peso,et al.  The Ras family of GTPases in cancer cell invasion , 2000, Cellular and Molecular Life Sciences CMLS.

[34]  A. Levinson,et al.  Expression of the H-ras proto-oncogene is controlled by alternative splicing , 1989, Cell.

[35]  A. Levinson,et al.  A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene , 1988, Nature.

[36]  X. Wan,et al.  Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma. , 2012, Cancer letters.

[37]  B. White,et al.  The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. , 2007, Molecular endocrinology.

[38]  O. Dereure [Mutations in H-Ras proto-oncogen in Costello syndrome]. , 2006, Annales de dermatologie et de venereologie.

[39]  E. Zackai,et al.  HRAS mutation analysis in Costello syndrome: Genotype and phenotype correlation , 2006, American journal of medical genetics. Part A.

[40]  J. Ferrer,et al.  Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein that trafficks to cytoplasm and nucleus. , 2003, Cancer research.

[41]  D. Lowy,et al.  Function and regulation of ras. , 1993, Annual review of biochemistry.